These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36814994)

  • 1. Genetic Variants in PHACTR1 & LPL Mediate Restenosis Risk in Coronary Artery Patients.
    Al Hageh C; Chacar S; Venkatachalam T; Gauguier D; Abchee A; Chammas E; Hamdan H; O'Sullivan S; Zalloua P; Nader M
    Vasc Health Risk Manag; 2023; 19():83-92. PubMed ID: 36814994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of polymorphism in PHACTR1 rs9349379 and rs12526453 with coronary artery atherosclerosis or coronary artery calcification. A systematic review.
    Koitsopoulos PG; Rabkin SW
    Coron Artery Dis; 2021 Aug; 32(5):448-458. PubMed ID: 33660664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus.
    Guneri S; Baris N; Aytekin D; Akdeniz B; Pekel N; Bozdemir V
    Int Heart J; 2005 Sep; 46(5):889-97. PubMed ID: 16272779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHACTR1 Gene Polymorphism Is Associated with Increased Risk of Developing Premature Coronary Artery Disease in Mexican Population.
    Pérez-Hernández N; Vargas-Alarcón G; Posadas-Sánchez R; Martínez-Rodríguez N; Tovilla-Zárate CA; Rodríguez-Cortés AA; Pérez-Méndez O; Blachman-Braun R; Rodríguez-Pérez JM
    Int J Environ Res Public Health; 2016 Aug; 13(8):. PubMed ID: 27517945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
    Zeng M; Yan X; Wu W
    BMC Cardiovasc Disord; 2021 Sep; 21(1):446. PubMed ID: 34535088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PHACTR1 gene polymorphism with the risk of coronary artery disease in Chinese Han population.
    Chen L; Qian H; Luo Z; Li D; Xu H; Chen J; He P; Zhou X; Zhang T; Chen J; Min X
    Postgrad Med J; 2019 Feb; 95(1120):67-71. PubMed ID: 30777881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Triglyceride Lipase Concentrations are Independent Risk Factors for Coronary Artery Disease and In-Stent Restenosis.
    Yu X; Lu J; Li J; Guan W; Deng S; Deng Q; Ye H; Han W; Yu Y; Zhang R
    J Atheroscler Thromb; 2019 Sep; 26(9):762-774. PubMed ID: 30651409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Study of Associations Between rs9349379 (PHACTR1), rs2891168 (CDKN2B-AS), rs11838776 (COL4A2) and rs4880 (SOD2) Polymorphic Variants and Coronary Artery Disease in Iranian Population.
    Yari A; Saleh-Gohari N; Mirzaee M; Hashemi F; Saeidi K
    Biochem Genet; 2022 Feb; 60(1):106-126. PubMed ID: 34109516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Biomarkers for Coronary Restenosis Occurrence After Drug-Eluting Stent Implantation in Patients With Diabetes Having Stable Coronary Artery Disease.
    Gabbasov Z; Kozlov S; Melnikov I; Byazrova S; Saburova O; Prokofieva L; Caprnda M; Curilla E; Gaspar L; Rodrigo L; Kruzliak P; Smirnov V
    Clin Appl Thromb Hemost; 2018 Nov; 24(8):1308-1314. PubMed ID: 29716394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between preheparin lipoprotein lipase mass concentration in serum and bare metal stent restenosis.
    Hitsumoto T; Takahashi M; Iizuka T; Shirai K
    J Cardiol; 2006 Aug; 48(2):65-73. PubMed ID: 16948449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis.
    Li X; Kong M; Jiang D; Dong A
    Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):347-54. PubMed ID: 24345688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus.
    Briguori C; Condorelli G; Airoldi F; Focaccio A; D'Andrea D; Cannavale M; Abarghouei AA; Giordano S; De Vivo F; Ricciardelli B; Colombo A
    Am J Cardiol; 2007 Mar; 99(6):779-84. PubMed ID: 17350364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention.
    Hu CP; Du Y; Zhu Y; Shi C; Qin Z; Zhao YX
    Chin Med J (Engl); 2018 Apr; 131(7):757-763. PubMed ID: 29578117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-196a2 (rs11614913) polymorphism is associated with coronary artery disease, but not with in-stent coronary restenosis.
    Fragoso JM; Ramírez-Bello J; Martínez-Ríos MA; Peña-Duque MA; Posadas-Sánchez R; Delgadillo-Rodríguez H; Jiménez-Morales M; Posadas-Romero C; Vargas-Alarcón G
    Inflamm Res; 2019 Mar; 68(3):215-221. PubMed ID: 30560371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for in-stent restenosis after coronary stent implantation in patients with coronary artery disease: A retrospective observational study.
    Zhang J; Zhang Q; Zhao K; Bian YJ; Liu Y; Xue YT
    Medicine (Baltimore); 2022 Nov; 101(47):e31707. PubMed ID: 36451388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes.
    Choi D; Kim SK; Choi SH; Ko YG; Ahn CW; Jang Y; Lim SK; Lee HC; Cha BS
    Diabetes Care; 2004 Nov; 27(11):2654-60. PubMed ID: 15505001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rate of in-stent restenosis after coronary intervention in carriers of the mutant mannose-binding lectin allele.
    Bagyura Z; Kiss L; Berta B; Szilágyi Á; Hirschberg K; Széplaki G; Lux Á; Szelid Z; Soós P; Merkely B
    BMC Cardiovasc Disord; 2017 Jan; 17(1):4. PubMed ID: 28056798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial Infarction-Associated SNP at 6p24 Interferes With MEF2 Binding and Associates With PHACTR1 Expression Levels in Human Coronary Arteries.
    Beaudoin M; Gupta RM; Won HH; Lo KS; Do R; Henderson CA; Lavoie-St-Amour C; Langlois S; Rivas D; Lehoux S; Kathiresan S; Tardif JC; Musunuru K; Lettre G
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1472-1479. PubMed ID: 25838425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing treatment failures in coronary artery disease: what can we learn from the biology of in-stent restenosis, vein graft failure, and internal thoracic arteries?
    Spadaccio C; Antoniades C; Nenna A; Chung C; Will R; Chello M; Gaudino MFL
    Cardiovasc Res; 2020 Mar; 116(3):505-519. PubMed ID: 31397850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.